1-alpha-24-dihydroxyvitamin-d3 has been researched along with Neurofibromatosis-1* in 1 studies
1 other study(ies) available for 1-alpha-24-dihydroxyvitamin-d3 and Neurofibromatosis-1
| Article | Year |
|---|---|
In vitro responses of neurofibroma fibroblasts, mast cells and Schwann cells obtained from patients with neurofibromatosis 1 to 308-nm excimer light and/or vitamin D3.
Fibroblasts, mast cells and Schwann cells were isolated from neurofibromas of patients with neurofibromatosis 1, and their responses to 308-nm excimer light irradiation and/or vitamin D3 or an analog (tacalcitol; 1,24-dihydroxyvitamin D3 ) were examined in vitro. Excimer light irradiation (300 mJ/cm(2) ) suppressed the growth of all three cell types. Exposure to 10(-7) mol/L of 1α,25(OH)2 D3 (VD3 ) or tacalcitol suppressed the growth of fibroblasts and mast cells, but not Schwann cells. These results suggest that the different neurofibroma cell types show different responses to VD3 . A combination of excimer light irradiation and VD3 is necessary to suppress the growth of neurofibroma cells in vivo. Topics: Cells, Cultured; Dermatologic Agents; Dihydroxycholecalciferols; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Lasers, Excimer; Low-Level Light Therapy; Mast Cells; Neurofibromatosis 1; Schwann Cells | 2013 |